User profiles for Sylvie Giacchetti
 | Sylvie Giacchettiaphp, hôpital saint louis, senopole Verified email at aphp.fr Cited by 12982 |
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival
…, A Valeanu, D Castaing, D Azoulay, S Giacchetti… - Annals of …, 2004 - journals.lww.com
Objective: To evaluate the long-term survival of patients resected for primarily unresectable
colorectal liver metastases (CRLM) downstaged by systemic chemotherapy and to use …
colorectal liver metastases (CRLM) downstaged by systemic chemotherapy and to use …
[PDF][PDF] Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
…, M Plasse, V Karam, F Lévi, S Giacchetti… - Journal of clinical …, 2006 - researchgate.net
… Thomas Aloia, Mylène Sebagh, Marylène Plasse, Vincent Karam, Francis Lévi, Sylvie
Giacchetti, Daniel Azoulay, Henri Bismuth, Denis Castaing, and René Adam … Giacchetti S …
Giacchetti, Daniel Azoulay, Henri Bismuth, Denis Castaing, and René Adam … Giacchetti S …
Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good …
…, J Waterhouse, P Bleuzen, S Giacchetti… - Clinical cancer …, 2000 - AACR
The rest/activity circadian cycle has been used as a reference for chemotherapy administration
at specific times to improve tolerability and efficacy. Because cancer processes may be …
at specific times to improve tolerability and efficacy. Because cancer processes may be …
Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer
D Groheux, S Giacchetti, JL Moretti, R Porcher… - European journal of …, 2011 - Springer
Purpose The aim of this study was to determine the impact of the main clinicopathological
and biological prognostic factors of breast cancer on 18 F-fluorodeoxyglucose (FDG) uptake. …
and biological prognostic factors of breast cancer on 18 F-fluorodeoxyglucose (FDG) uptake. …
Is liver resection justified for patients with hepatic metastases from breast cancer?
…, J Krissat, MP Bralet, B Paule, S Giacchetti… - Annals of …, 2006 - journals.lww.com
Objective: The purpose of this study was to examine our experience with hepatic resection (HR)
in a relatively unselected group of patients with breast cancer liver metastases (BCLM). …
in a relatively unselected group of patients with breast cancer liver metastases (BCLM). …
Performance of FDG PET/CT in the clinical management of breast cancer
D Groheux, M Espié, S Giacchetti, E Hindié - Radiology, 2013 - pubs.rsna.org
In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …
[HTML][HTML] p53 in breast cancer subtypes and new insights into response to chemotherapy
…, E Bourstyn, P de Cremoux, A Janin, S Giacchetti… - The Breast, 2013 - Elsevier
Despite an obvious central role of p53 in the hallmarks of cancer, TP53 status is not yet used
for the management of breast cancer. Recent findings may lead to reconsider the role of …
for the management of breast cancer. Recent findings may lead to reconsider the role of …
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer
…, T Moreau, C Garufi, J Waterhouse, S Giacchetti… - Cancer research, 2009 - AACR
The rest-activity circadian rhythm (CircAct) reflects the function of the circadian timing system.
In a prior single-institution study, the extent of CircAct perturbation independently predicted …
In a prior single-institution study, the extent of CircAct perturbation independently predicted …
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of …
S Giacchetti, G Bjarnason, C Garufi, D Genet… - Journal of clinical …, 2006 - ascopubs.org
Purpose In two previous randomized trials, the adjustment of chemotherapy delivery to
circadian rhythms improved tolerability and anticancer activity compared with constant-rate …
circadian rhythms improved tolerability and anticancer activity compared with constant-rate …
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
…, B Baron, F Kreutz, S Giacchetti - Advanced drug delivery …, 2007 - Elsevier
The circadian timing system controls drug metabolism and cellular proliferation over the 24 h
through molecular clocks in each cell, circadian physiology, and the suprachiasmatic nuclei …
through molecular clocks in each cell, circadian physiology, and the suprachiasmatic nuclei …
